Roberto Bolli, M.D.

Roberto Bolli, M.D., FAHA Professor of Medicine, Physiology and Biophysics Chief, Division of Cardiovascular Medicine Executive Vice Chair, Department of Medicine Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology Distinguished University Scholar University of Louisville Health Care Outpatient Center 401 East Chestnut Street, Ste. 310 Louisville, KY 40202 502-852-7959 - Academic Office 502-813-6500 - Patient Appointments

Clinical Expertise

Cardiology; Cardiovascular Disease

Board Certification

• American Board of Internal Medicine - Internal Medicine / Cardiovascular Disease

Education and Training

• Medical School: University of Perugia, Italy

• Residency: Baylor College of Medicine

• Fellowship: National Institutes of Health; Baylor College of Medicine

Recent Publications

• Guo Y, Sanganalmath SK, Wu W, Zhu X, Huang Y, Tan W, Ildstad ST, Li Q, Bolli R. Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2012 Mar;107(2):253. Epub 2012 Feb 21.

• Bolli R; for the Editors. The Ten Most Read Articles Published in Circulation Research in 2011. Circ Res. 2012 Feb 17;110(4):e24-e28. Epub 2012 Jan 31.

• Li JJ, Lu ZL, Kou WR, Bolli R, Chen Z, Wu YF, Yu XH, Zhao YC. Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS). Int J Cardiol. 2012 Feb 9;154(3):362-5. Epub 2011 Dec 1.

• Stein AB, Bolli R, Dawn B, Sanganalmath SK, Zhu Y, Wang OL, Guo Y, Motterlini R, Xuan YT. Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol. 2012 Jan;52(1):228-36. Epub 2011 Nov 19.

• Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011 Nov 26;378(9806):1847-57. Epub 2011 Nov 14.

• Li Q, Guo Y, Ou Q, Wu WJ, Chen N, Zhu X, Tan W, Yuan F, Dawn B, Luo L, Hunt GN, Bolli R. Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol. 2011 Nov;106(6):1367-77. Epub 2011 Jul 22.

• Li Q, Guo Y, Wu WJ, Ou Q, Zhu X, Tan W, Yuan F, Chen N, Dawn B, Luo L, O'Brien E, Bolli R. Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol. 2011 Nov;106(6):1355-66. Epub 2011 Jul 21.

• Schwartz Longacre L, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Mentzer RM, Murphy E, Ovize M, Ping P, Przyklenk K, Sack MN, Vander Heide RS, Vinten-Johansen J, Yellon DM; National Heart, Lung, and Blood Institute, National Institutes of Health. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation. 2011 Sep 6;124(10):1172-9.

• Bolli R. A new standard in the conflict of interest policy of the American Heart Association. Circ Res. 2011 Sep 2;109(6):608.

• Sanganalmath SK, Abdel-Latif A, Bolli R, Xuan YT, Dawn B. Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond. Basic Res Cardiol. 2011 Sep;106(5):709-33. Epub 2011 May 4. Review.